Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
MRNA Stock Alert: What to Know as U.K. Approves Updated Moderna Booster
11:38am, Monday, 15'th Aug 2022
The U.K.'s regulatory authority just approved Moderna's (NASDAQ: MRNA ) bivalent Covid-19 booster vaccine called mRNA-1273.214. Bivalent means it addresses two strains of Covid-19, and this particula
Stocks gaining in early trading: Nvidia, AMD, Tesla, Moderna, Gilead
11:01am, Monday, 15'th Aug 2022
Yahoo Finance Live's Brad Smith breaks down how stocks are moving in early trading.
Should Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) Be on Your Investing Radar?
10:20am, Monday, 15'th Aug 2022 Zacks Investment Research
Style Box ETF report for QQQE
U.K. regulator is first to authorize Moderna's bivalent COVID booster for adults aged 18 and older
10:04am, Monday, 15'th Aug 2022
The U.K. regulator has become the first to authorize Moderna's bivalent COVID vaccine booster for use in adults aged 18 and older.
Moderna's Omicron Booster Approved In The U.K. In World First
08:33am, Monday, 15'th Aug 2022
The booster shot targets two coronavirus variants and contains half omicron-specific vaccine and half original vaccine.
UK regulator authorizes Moderna bivalent COVID vaccine booster for adults aged 18 and older
07:13am, Monday, 15'th Aug 2022
Moderna Inc. MRNA, -0.37% said Monday the U.K. regulator has authorized its bivalent COVID vaccine booster for use in adults aged 18 and older. The Medicines and Healthcare products Regulatory Agency
What Happened This Week: Musk Braces For Fight, Disney And Coinbase
02:26pm, Saturday, 13'th Aug 2022 Investing.com
Here's How This Beaten-Down Stock Could 10X by 2024
01:45pm, Saturday, 13'th Aug 2022 The Motley Fool
A moonshot won't be necessary, but it'll require a bit of a pivot.
Wall Street Breakfast: What Moved Markets
12:24pm, Saturday, 13'th Aug 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
2022 Returns For Investor And Pandemic Darlings: You Won't Believe This Stock That Is Positive On The Year
08:55pm, Wednesday, 10'th Aug 2022 Benzinga
2022 has been an uncertain year in the markets, to say the least.
A number of second-quarter big tech earnings were delivered in recent weeks, showing signs of stability in the macro environment and
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
05:15pm, Wednesday, 10'th Aug 2022 The Motley Fool
As a result of some bad news, the market might be underestimating its chances of a comeback.
With Growth Slowing, Is Moderna Stock Still Worth A Look?
05:00am, Wednesday, 10'th Aug 2022
While Moderna's revenue grew by about 9% year-over-year to $4.
China closes Tibet's Potala Palace over COVID outbreak, and Novavax stock is slammed by weak earnings and halving of sales guidance
05:48pm, Tuesday, 09'th Aug 2022 MarketWatch
Chinese authorities have closed Tibet's Potala Palace after a small outbreak of COVID cases in the Himalayan region, the Associated Press reported Tuesday.
Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half
04:09pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Novavax (NVAX) reports dismal results in second-quarter 2022. The stock dives in after-market trading after management slashes revenue guidance for 2022 by half.
Novavax slashes sales guidance in half, stock plunges 34%
12:28pm, Tuesday, 09'th Aug 2022 MarketWatch
Novavax Inc. executives slashed their annual sales guidance in half on Monday while wildly missing financial expectations, sending shares down more than 30% in after-hours trading.
